LEP and lipodystrophy: While in in vitro models of hepatocytes, leptin caused the gene and protein expression of PCSK9 to rise [47] and had no effect on plasma PCSK9 in female ob/ob mice, leptin treatment reduced plasma PCSK9 in female patients with lipodystrophy [48].